Connect with us

Hi, what are you looking for?

Jewish Business News


University of East Anglia Study: Cooperation between Cancer Cells Makes Therapies Ineffective

Cancer Cells

Cooperation between cancer cells makes current therapies ineffective but also suggests new treatment. Researchers at the University of East Anglia have made an important step in understanding why many cancers are difficult to treat and come back following treatment.

They have shown that cancer cells cooperate with each other in the production of growth factors, diffusible molecules produced by the cancer cells that are essential for tumour progression.

The findings, published today in the journal PNAS, help to explain why therapies that target growth factors are prone to the evolution of resistance and why relapses happen after treatment.

It is hoped that the findings will lead to a new type of treatment involving genetically modified cancer cells being reinserted into a tumour.

Lead researcher Dr Marco Archetti, from UEA’s School of Biological Sciences said: “The cancerous cells that make up a tumour often show different profiles – for example in their shape and appearance, in the genes they express, or their potential to spread to other parts of the body. This is called tumour heterogeneity, and these differences make cancer diagnosis and treatment difficult.

“It is not clear why heterogeneity exists, but understanding its origin and dynamics is essential for treating cancer.”

The research team studied pancreatic cancer cells in the lab and used mathematical models to show why heterogeneity persists within a tumour.

“We have shown that cancer cells cooperate with each other. A tumour is a group of cells that have an advantage against normal cells, due to the fact that cancer cells produce their own molecules that stimulate growth – known as growth factors. We have shown that cancer cells that do not produce growth factors can ‘free-ride’ on the growth factors produced by other cooperative cancer cells. The two types – co-operators and free-riders – can form a heterogeneous tumour under certain circumstances.

“Cancer is an evolutionary process of selection among cells on the timescale of an individual’s lifetime, and when a drug modifies the amount of available growth factors it also make the tumour evolve. A heterogeneous tumour can easily adapt to changing amounts of growth factors, which is why current therapies against cancer are unstable and why relapses happen post treatment.”

As well as studying pancreatic cancer cells, researchers repeated their experiments with other cancer types. They are currently screening a large number of cancer types and growth factors.

Dr Archetti’s team is now working towards a new kind of cell therapy. They plan to genetically modify cancer cells by removing the genes which control the production of growth factors. They will then reinsert these modified cells into the tumour.

Laboratory experiments show that, under the right conditions, these modified cells spread like a tumour within the tumour, driving the original, cooperative cells to extinction – instead of leading to heterogeneity. This would cause the tumour to collapse because of a lack of growth factors.

1 Comment

1 Comment

  1. Shapoval

    January 31, 2015 at 9:24 pm

    at the University of East Anglia can beat Cancer. Lead researcher Dr Marco
    Archetti, from UEA’s School of Biological Sciences said: The cancerous cells
    that make up a tumor often show different profiles. This is called tumor
    heterogeneity, and these differences make cancer diagnosis and treatment
    difficult. The Father of Oncology says that at the
    cellular level, cancer occurs when cellular iron overload chaotically affects
    cellular organelles. There are many types of organelles. Cellular iron overload
    can chaotically affect DNA, chromosomes, mitochondria, lysosomes, etc. That’s
    why heterogeneity persists within all tumors. Molecular heterogeneity of tumors
    suggests the presence of multiple different subclones. Cancerous cells contain
    innumerable errors/mistakes in genetic material. Primary tumors always develop
    at body sites of excessive iron deposits. Such deposits can be inherited from
    parents or can be acquired during life. Cancer Research UK uses the slogan One
    Day We Will Beat Cancer. Researchers at the University of East Anglia will beat
    cancer if they can understand clinical iron/cancer information. Surgery
    (ceramic blades) and direct intratumoral injections of iron-deficiency agents
    (ceramic needles) can successfully eliminate tumors and metastases. Clinical
    iron-deficiency methods (special diets; accurate blood donations) can

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...


Now Platika joins and elite club of $10 billion plus Israeli firms.

cialis cialis satış